Sentinel lymphadenectomy in breast cancer: An alternative to routine axillary dissection

被引:9
作者
Noguchi M. [1 ,2 ]
Kawahara F. [2 ]
Tsugawa K. [2 ]
Bando E. [2 ]
Miwa K. [2 ]
Yokoyama K. [3 ]
Nakajima K.-I. [3 ]
Tonami N. [3 ]
机构
[1] Operation Center, Kanazawa University Hospital, School of Medicine, Kanazawa 920, Takara-machi
[2] Department of Surgery II, Kanazawa University Hospital, School of Medicine
[3] Department of Nuclear Medicine, Kanazawa University Hospital, School of Medicine
关键词
Axillary dissection; Breast cancer; Sentinel lymphadenectomy;
D O I
10.1007/BF02967410
中图分类号
学科分类号
摘要
We reviewed the literature concerning sentinel lymphadenectomy in breast cancer and reached the following conclusions: (a) A combination of lymphoscintigraphy and dye-guided and/or gamma probeguided techniques are superior to either technique alone for identifying the sentinel lymph node, (b) Immediate and reliable intraoperative information on the sentinel node is vital for the technique's success. However, the reliability of sentinel node diagnosis using frozen sections is questionable, because micrometastatic foci cannot be identified, (c) A reverse transcriptase-polymerase chain reaction (RT-PCR) method is more sensitive than immunohistochemistry for the detection of micrometastasis in the sentinel node, (d) Until there are new tumor markers or new imaging techniques to identify axillary metastasis without operative intervention, sentinel lymphadenectomy is a highly accurate, minimally invasive way to assess disease extent. Before sentinel lymphadenectomy gains general acceptance for patients with primary breast cancer, however, a large clinical trial will be essential to verify the value of this technology.
引用
收藏
页码:1 / 6
页数:5
相关论文
共 52 条
[1]  
Fisher B., Redmond C., Fisher E.R., Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation, New England Journal of Medicine, 312, 11, pp. 674-681, (1985)
[2]  
Veronesi U., Valagussa P., Inefficacy of internal mammary nodes dissection in breast cancer surgery, Cancer, 47, 1, pp. 170-175, (1981)
[3]  
Noguchi M., Miwa K., Michigishi T., Et al., The role of axillary lymph node dissection in breast cancer management, Breast Cancer, 4, pp. 143-153, (1997)
[4]  
Noguchi M., Kinne D.W., Miyazaki I., Controversies in the surgical management of operable breast cancer, Breast Cancer, 1, pp. 79-88, (1994)
[5]  
Senofsky G.M., Moffat Jr. F.L., Davis K., Et al., Total axillary lymphadenectomy in the management of breast cancer, Arch Surg, 126, pp. 1336-1342, (1991)
[6]  
Donegan W.L., Surgical clinical trials, Cancer, 53, 3 SUPPL., pp. 691-699, (1984)
[7]  
Fentiman I.S., Mansel R.E., The axilla
[8]  
not a no-go zone, Lancet, 337, pp. 221-223, (1991)
[9]  
Kissin M.W., Querci Della Rovere G., Easton D., Et al., Risk of lymphedema following the treatment of breast cancer, Br J Surg, 73, pp. 580-585, (1986)
[10]  
Wazer D.E., Erban J.K., Robert N.J., Smith T.J., Marchant D.J., Schmid C., DiPetrillo T., Schmidt-Ullrich R., Breast conservation in elderly women for clinically negative axillary lymph nodes without axillary dissection, Cancer, 74, 3 SUPPL., pp. 878-883, (1994)